From 2025 to 2035, residual current circuit breaker market is expected to flourish at a CAGR of 6.7%. By 2035, the market ...

Her work has previously appeared in theGrio, Shondaland and ESSENCE GU. Jenna Bush Hager/Instagram Jenna Bush Hager is soaking in all the love for Mother's Day. On Sunday, May 11, the Today with ...

PHILADELPHIA and VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell ...

Phase 3 clinical data shows potential predictive biomarkers for treatment response, first identified in Phase 2 study Biomarkers could be utilized to predict and provide better patient outcomes, ...

Mumbai: A major boost to Mumbai’s public transport infrastructure is on the horizon as Phase 2A of the underground Mumbai Metro Line 3, also known as Aqua Line, connecting Bandra-Kurla Complex ...

as the S&P 500 slipped toward the threshold that would trigger an initial “circuit breaker.” The S&P 500 SPX was down 4.6% near 4,200 in recent trade, after hitting a session low at 5,115.27 ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to ...

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is currently evaluating mavorixafor in a Phase 3 clinical trial in chronic neutropenia (CN) patients. The 4WARD trial is expected to enroll a total of 150 ...

The New York City central nervous system (CNS) specialist has scored in a phase 3 trial testing Sunosi (solriamfetol) on adults with attention deficit hyperactivity disorder (ADHD). The study ...

The Company also announced that it now expects to report topline data from its pivotal Phase 3 ONWARD clinical program of ESK-001 for the treatment of moderate-to-severe PsO in the first quarter of ...